CIK 0001851484 · <br>Emerging growth company
CITIUS ONCOLOGY, INC.
Sign in to watch- Ticker
- CTOR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 994362660
- Phone
- (908) 967-6677
- Business address
- 11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD, NJ, 07016
- Former names
- TenX Keane Acquisition
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-12 | HOLUBIAK MYRON Z Secretary | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-12-12 | Smith Robert Joseph Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2024-12-12 | Webb Carol Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2024-12-12 | Dutia Suren G Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2024-12-12 | MCGRATH DENNIS M Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2024-12-12 | Bartushak Jaime Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2024-12-12 | Mazur Leonard L Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +800,000 | 800,000 | ||
| 2024-12-12 | Czuczman Myron Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2024-08-12 | Mazur Leonard L Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +3,700,000 | 3,700,000 | ||
| 2024-08-12 | HOLUBIAK MYRON Z Director | Grant or award · Stock Option (Right to Buy) | +1,500,000 | 1,500,000 | ||
| 2024-08-12 | Czuczman Myron Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +1,400,000 | 1,400,000 | ||
| 2024-08-12 | Bartushak Jaime Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +1,400,000 | 1,400,000 | ||
| 2024-08-12 | Holuka Eugene Myron Director | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2024-08-12 | Dutia Suren G Director | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2024-08-12 | HOLUBIAK MYRON Z Director | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2024-08-12 | Czuczman Myron Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +466,667 | 466,667 | ||
| 2024-08-12 | Mazur Leonard L Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,233,333 | 1,233,333 | ||
| 2024-08-12 | Bartushak Jaime Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +466,667 | 466,667 | ||
| 2024-08-12 | MCGRATH DENNIS M Director | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2024-08-12 | Webb Carol Director | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 |
Page 3 of 3 · 60 trades